Skip to main content
Caplight Logo









WeWALK

WeWALK

Private
LondonHealthcare & Life Scienceshttps://wewalk.io/en/

Last Round

VC Round

Nov 10, 2025

Total Funding Raised

$5.21M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

WeWALK is a therapeutic devices company that develops AI-powered smart canes and mobility software to increase the independence of visually impaired individuals.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Consumer Electronics, Public Transit, Computer Vision

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

assistive technologysmart canevisually impairedaccessibility softwareobstacle detectionblind navigationassistive hardwarehealth IoTsoftware development kitSDKorientation and mobilitydisability techsmart mobilityaccessibility toolswearable tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

WeWALK Comparables

Compare WeWALK with similar companies based on industry and business-model similarity.

WeWALK comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Envision
85%
dotLumen
85%
MakeSense Technology
83%

WeWALK Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 10, 2025
SeedFeb 27, 2024
SeedDec 8, 2022
GrantJul 4, 2022
SeedJun 2, 2020

Key People

Founding team and executive leadership

Gökhan Meriçliler

Co-Founder & CEO

Founding Team

WeWALK Investors

Notable investors and investment history

WeWALK investors
InvestorRounds
NEC XVC Round, Seed
UKRI Innovate UKGrant
Nesta Impact InvestmentsSeed
Vestel VenturesSeed
Draper AssociatesVC Round
APY VenturesSeed, VC Round
Meridian Health VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 45% MoM.

  • Nov 10, 2025

    $900K round led by Draper Associates.

WeWALK Filings

Explore SEC and related filing metadata, where available.

WeWALK filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about WeWALK's valuation, stock price, and market status.

Is WeWALK a public or private company?

WeWALK is a private company.

What is the current stock price of WeWALK?

WeWALK is a private company with no public stock price. No recent secondary market data is available.

How much is WeWALK worth (valuation)?

Valuation information for WeWALK is not publicly available.

Can I buy WeWALK stock?

WeWALK shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was WeWALK's last funding round?

WeWALK's most recent funding round was Seed on February 27, 2024.

Who are the main investors in WeWALK?

Key investors in WeWALK include NEC X, Nesta Impact Investments.

Will WeWALK IPO soon?

No public IPO plans have been announced for WeWALK.

How can I track WeWALK secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor WeWALK's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range35
Year Founded2017
Last FundingNov 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?